2/16/2021 - Studying the Elimination of Anti-Rejection Medications KidneyTalk - An Online Radio Show By Renal Support Network

    • Health & Fitness

Kidney transplant recipients deal with taking anti-rejection meds for life. Talaris is developing an alternative to immunosuppression. Nancy Krieger, MD, Talaris Therapeutics Chief Medical Officer, explains how this new treatment will work and how it differs from what is currently prescribed. She also talks about how you can learn more about the clinical trials that are available.

Kidney transplant recipients deal with taking anti-rejection meds for life. Talaris is developing an alternative to immunosuppression. Nancy Krieger, MD, Talaris Therapeutics Chief Medical Officer, explains how this new treatment will work and how it differs from what is currently prescribed. She also talks about how you can learn more about the clinical trials that are available.

Top Podcasts In Health & Fitness

The School of Greatness
Lewis Howes
Huberman Lab
Scicomm Media
Soothing Sleep
OpenMind
ZOE Science & Nutrition
ZOE
Passion Struck with John R. Miles
John R. Miles
The Doctor's Farmacy with Mark Hyman, M.D.
Dr. Mark Hyman